Eli Lilly (LLY) vs Apple (AAPL)
The GLP-1 story vs. the iPhone economy.YourBet.ai Education Team · Last updated 2026-09-16
Eli Lilly — Eli Lilly makes some of the world's best-selling GLP-1 medicines for diabetes and weight loss (Mounjaro, Zepbound). Demand has been so strong that supply — not customers — is often the limiting factor.
Apple — Apple still makes most of its money from iPhones, but the growth story has quietly shifted to Services — the App Store, iCloud, Apple Pay, ads — where margins are much higher. AAPL is often used as a proxy for global consumer demand.
What each company does
Lilly is a global pharmaceutical company with strong franchises in diabetes, obesity, oncology and neuroscience. Its GLP-1 portfolio has redefined how markets value obesity as a therapeutic category.
Apple designs iPhones, Macs, iPads, Watches and AirPods, and runs one of the largest software ecosystems in the world. Roughly a quarter of revenue now comes from Services — a high-margin, recurring business that Wall Street loves.
What moves each stock
- ›GLP-1 sales, manufacturing capacity and insurance coverage.
- ›Clinical trial readouts for next-generation obesity and Alzheimer's drugs.
- ›Regulatory decisions in the US, EU and China.
- ›Competition, especially from Novo Nordisk's Ozempic/Wegovy franchise.
- ›iPhone cycle: launches, upgrade rates and China demand.
- ›Services revenue growth and margin — the metric investors watch most closely.
- ›AI features rolling out across iPhone, Mac and Vision Pro.
- ›Regulatory pressure on the App Store commission model.
- ›Gross margin mix — every point of Services growth lifts the blended margin.
- ›The dollar: most of Apple's revenue is earned outside the US, so currency swings show up in reported growth.
Key differences
- ›Business model: Eli Lilly makes money differently than Apple — see the "What each company does" section above.
- ›Growth drivers: the two stocks react to different news flows — compare the "What moves" lists side by side.
- ›Live numbers: price, market cap and 52-week range live on each ticker page.
Frequently asked questions
What's the difference between LLY and AAPL?
Eli Lilly focuses on: Lilly is a global pharmaceutical company with strong franchises in diabetes, obesity, oncology and neuroscience. Its GLP-1 portfolio has redefined how markets value obesity as a therapeutic category. Apple focuses on: Apple designs iPhones, Macs, iPads, Watches and AirPods, and runs one of the largest software ecosystems in the world. Roughly a quarter of revenue now comes from Services — a high-margin, recurring business that Wall Street loves.
Which is bigger, LLY or AAPL?
Company size changes with the market. See the live market-cap numbers on their individual pages: /stock/LLY and /stock/AAPL.
Is LLY or AAPL a better investment?
YourBet.ai does not give investment advice. We explain what each company does and what moves its stock — the decision is yours, and your capital is at risk.
What moves LLY vs AAPL?
LLY is driven by: GLP-1 sales, manufacturing capacity and insurance coverage. Clinical trial readouts for next-generation obesity and Alzheimer's drugs. AAPL is driven by: iPhone cycle: launches, upgrade rates and China demand. Services revenue growth and margin — the metric investors watch most closely.
This is an affiliate link. If you sign up, YourBet.ai may earn a commission — at no extra cost to you. We only feature providers we believe are relevant for anyone. Not financial advice.
Your capital is at risk. This is not investment advice.
Educational content — not financial advice. We explain what companies do and what moves their stocks. We do not recommend buying or selling.